Table 2:
Variable | Adjusted Hazard Ratio (95% CI) | p-value |
---|---|---|
Treatment with anti-VEGF antibody | 0.62 (0.28–0.99) | 0.049 |
Age | 0.92 (0.82–1.03) | 0.16 |
Sex | 0.86 (0.55–1.34) | 0.51 |
Race/Ethnicity | ||
1) Blacks vs. Non-Hispanic Whites | 1.25 (0.65–2.39) | 0.48 |
2) Hispanic Whites vs. Non-Hispanic Whites | 1.28 (0.65–2.53) | 0.47 |
3) Blacks vs. Hispanic Whites | 0.97 (0.60–1.57) | 0.92 |
ECOG Performance Status | 1.34 (0.97–1.85) | 0.07 |
Total Number of Metastases | 1.19 (1.05–1.35) | 0.005 |
EGFR mutation status (ex19del/ex21 L858R) | 0.33 (0.14–0.79) | 0.01 |